# US 2024/0197531 A1 · Methods for implanting intraocular shunts

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0197531 A1
- Document ID: US20240197531A1
- Status: Published application
- Kind: A1
- Application number: 18/494,154
- Filed: 2023-10-25
- Published: 2024-06-20
- Earliest claimed: 2010-11-15
- Assignees: AqueSys, Inc.
- Applicants: AqueSys, Inc.
- Inventors: Christopher Horvath; Laszlo O. Romoda; Guenther Grabner; Herbert A. Reitsamer
- Web page: https://patentgrep.com/patent/US20240197531A1

## CPC

- A61F 9/00781: {Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment (drainage implants in general A61M27/002)}
- A61B 17/3415: {for introducing tubes or catheters, e.g. gastrostomy tubes, drain catheters (A61B17/3417 takes precedence; body piercing catheter guide needles A61M25/06)}
- A61B 17/3468: {for implanting or removing devices, e.g. prostheses, implants, seeds, wires (devices for implanting seeds A61M37/0069)}
- A61B 17/3417: {Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating (syringe needles A61M5/32; dilators A61M29/00)}
- A61F 9/0008: {Introducing ophthalmic products into the ocular cavity or retaining products therein (putting in contact lenses A61F9/0061; introducing or retaining media in cavities of the body in general A61M31/00)}
- A61F 9/0017: {implantable in, or in contact with, the eye, e.g. ocular inserts}
- A61F 9/007: Methods or devices for eye surgery
- A61M 27/002: {Implant devices for drainage of body fluids from one part of the body to another (intraocular A61F9/00781; middle ear A61F11/202)}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Glaucoma can be treated by implanting an intraocular shunt into the eye. Such procedures can employ various deployment devices, shunts, and implantation techniques. A method of treating glaucoma can be performed by a clinician, in which a hollow needle is inserted into an eye through the sclera. The hollow needle can carry an intraocular shunt. Once inserted and properly positioned, the clinician can release the shunt from the needle such that the shunt conducts fluid away from the anterior chamber of the eye.

## Claims

### Claim 1

(canceled)

### Claim 2

An ab externo method of placing an intraocular shunt into an eye, the method comprising the steps of:
advancing a needle, in which the shunt is disposed, into the eye through conjunctiva and sclera of the eye;
positioning an outlet end portion of the shunt in a subconjunctival region of lower pressure the eye; and
releasing the intraocular shunt to create a fluid-flow pathway from the anterior chamber to the subconjunctival region of lower pressure.

### Claim 3 (depends on 2)

The method of claim 2, further comprising positioning an inlet end portion of the shunt in the anterior chamber.
The method of claim 2, wherein the advancing comprises piercing the Tenon's capsule of the eye.

### Claim 4 (depends on 2)

The method of claim 2, wherein the shunt comprises a pharmaceutical or biological agent.

### Claim 5

An ab externo method of treating glaucoma comprising:
inserting, into an eye through the sclera, a hollow needle carrying an intraocular shunt and
releasing the shunt from the needle such that the shunt conducts fluid away from the anterior chamber of the eye to a subconjunctival region.

### Claim 6 (depends on 5)

The method of claim 5, wherein the inserting comprises piercing the Tenon's capsule of the eye.

### Claim 7 (depends on 5)

The method of claim 5, further comprising positioning an inlet end portion of the shunt in the anterior chamber.

### Claim 8 (depends on 5)

The method of claim 5, wherein the shunt comprises a pharmaceutical or biological agent.

### Claim 9 (depends on 5)

The method of claim 5, wherein the pharmaceutical or biological agent comprises a coating on a surface of the shunt.

### Claim 10

A method for implanting a shunt in a suprachoroidal space of an eye, the method comprising:
providing a device comprising: a housing; a deployment mechanism at least partially disposed within the housing; and a flexible hollow shaft coupled to the deployment mechanism and disposed within the shaft in a less curved configuration, less curved than the curved configuration, wherein the shaft holds an intraocular shunt, and is configured to guide the shunt along a scleral spur of an eye as the shunt is exposed from the shaft;
inserting the device into the eye; and
advancing the shaft out of the housing, whereby the shaft transitions from the less curved configuration to a curved configuration.

### Claim 11 (depends on 10)

The method of claim 10, further comprising exposing the shunt from the shaft along a curved pathway, defined by the shaft in the curved configuration, within the eye such that a proximal portion of the shunt resides in and receives fluid from an anterior chamber of an eye and a distal portion of the shunt resides in and directs the fluid to the suprachoroidal space.
